Prostate cancer study tests drug to reduce harmful AGE levels
NCT ID NCT02946996
First seen Mar 06, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study looked at whether a drug called OPC could lower AGE levels in men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). AGEs are substances that can build up in the body and may cause health problems. The study planned to enroll 41 participants but was stopped early. The main goal was to see if OPC could reduce AGE levels by at least 30% in half of the participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.